GERIANNE FERRER: Open Payments
NPI 1770203747 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$850 in 46 payments from 11 companies in 2025. Trend: 2023 $350 · 2024 $761 · 2025 $850
Food & beverage: $850
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $196 |
| Lilly USA, LLC | 11 | $152 |
| Novo Nordisk Inc | 7 | $146 |
| PFIZER INC. | 3 | $77 |
| Amgen Inc. | 3 | $70 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| Exact Sciences Corporation | 2 | $40 |
| Astellas Pharma US Inc | 1 | $22 |
| Curonix LLC | 1 | $21 |
Products named: Kerendia, MOUNJARO, Ozempic, OTEZLA, AIRSUPRA, Rybelsus, ELIQUIS, Cologuard Collection Kit.
Industry payments across NV — which companies pay providers there.
